Alzheimer's Disease Genetics Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

10000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2002-06-30

Study Completion Date

2026-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the Alzheimer's Disease Genetics Study is to identify the genes that are responsible for causing Alzheimer's Disease (AD). One of the ways in which the risk factor genes for late onset AD can be investigated is by identifying and collecting genetic material from families with multiple members diagnosed with AD or dementia.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Genetic Studies in Familial Dementia

NCT04680013

Dementia of Alzheimer Type Alzheimer Disease, Late Onset Alzheimer Disease, Early Onset +2 more

COMPLETED

The Genetic Characterization of Dementia

NCT01867359

Dementia

COMPLETED

A Genetic Study for Alzheimer Dementia: Case-control Study

NCT06330155

Alzheimer Dementia (AD)

NOT_YET_RECRUITING

Early Onset Alzheimer's Disease Genomic Study

NCT03645993

Alzheimer Disease

COMPLETED

Genetic Studies in Alzheimer's Disease

NCT00001235

Alzheimer's Disease Nervous System Disease

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The purpose of the Alzheimer's Disease Genetics Study is to help identify the genes that may be responsible for causing Alzheimer's Disease (AD) by collecting genetic material from families with multiple members diagnosed with AD. Qualifying families will have two living blood-related individuals who have been diagnosed with or are showing symptoms of AD or dementia. Local study sites are located all over the United States, and arrangements may be made for eligible families who do not live near a participating site. The biological samples and data from these families will be made available to qualified researchers, who must sign a Materials Transfer Agreement (MTA) in order to protect the privacy rights of study participants before receiving samples and data.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Alzheimer Disease Late Onset Alzheimer Disease Dementia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Two living family members diagnosed with AD or other dementia with any age of onset
* Biological samples available

* Fresh blood, or
* Immortalized lymphoblastic cell lines, or
* 3-5 grams of frozen cerebral cortex; fixed samples are not accepted

Please note: this study does not include genetic counseling; because no personal identifying information such as name or date of birth is attached to samples, results of individual tests are not available to participants or family members.

* Member of a family that was included in the National Institute of Mental Health AD Genetics Sib Pair collection

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes